T2 mapping was applied retrospectively to healthy subjects, mild cognitive impairment (MCI) and Alzheimer’s disease (AD) by deriving the T2 from modelling standard dual-echo proton density and T2-weighted fast spin echo sequence, as used in the Alzheimer’s disease and Neuroimaging Initiative (ADNI-1). T2 differences were compared to volume changes in hippocampus and thalamus. In both regions, T2 mapping showed significant differences between MCI and healthy subjects while volume measures did not. Volume was more effective for distinguishing MCI from AD, due to profound hippocampal atrophy. By modelling actual refocusing angles, T2 mapping revealed differences between healthy, MCI and Alzheimer’s subjects.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords